SEC-PR-2412-189 (Dec. 3, 2024) (SEC-PR-2412) SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews – SEC declines to impose civil penalties against company due to its self-reporting, remediation, and cooperation. Excerpt: Washington D.C., Dec. 3, 2024 — The Securities and Exchange Commission today filed settled charges against […]
Day: December 3, 2024
SEC-PR-2412-190 (Dec. 3, 2024) (SEC-PR-2412) SEC Investor Advisory Committee to Examine Mandatory Arbitration Clauses in Adviser Agreements and Alternative Assets and Retail Investors at December 10 Meeting Excerpt: Washington D.C., Dec. 3, 2024 — The Securities and Exchange Commission’s Investor Advisory Committee will hold a virtual public meeting on Dec. 10, 2024, at 10 a.m. […]
CFPB-PR-241203-1 (12-03-24) (CFPB-PR-2412) CFPB Proposes Rule to Stop Data Brokers from Selling Sensitive Personal Data to Scammers, Stalkers, and Spies – Rule seeks to protect Americans from crime and illegal foreign surveillance Excerpt: WASHINGTON, D.C. – The Consumer Financial Protection Bureau (CFPB) today proposed a rule to rein in data brokers that sell Americans’ sensitive personal and […]